ＡＸＩＵＭ　ＣＡＰＩＴＡＬ　ＰＴＥ．ＬＴＤ． Raises Stake in 綜研化学 (4972) to 23.61% | Large Shareholding Report

A large shareholding report (EDINET filing) shows that Axiom Capital PTE. LTD. has raised its stake in Soken Chemical (4972) to 23.61%. This represents a substantial investment by a Singapore-based investment company. Soken Chemical operates in the chemical sector, and this ownership stake comprises roughly one quarter of the company's outstanding shares, positioning Axiom as a major shareholder. The holding increased by 1.01 percentage points from the previous disclosure, reflecting a series of incremental purchases.

Building a 23.61% stake through 13 filings over eight months

Axiom Capital first disclosed its position in Soken Chemical on November 10, 2025, when it held 6.72% of the company. Between that initial filing and the July 30, 2026 report, the firm submitted 13 large shareholding reports, accumulating a stake that grew nearly 17 percentage points. The estimated acquisition amount in this particular report stands at ¥500 million, but this represents one step within a broader accumulation strategy executed at varying prices over the eight-month period. At the July 30 reference price of ¥3,010 per share, the most recent purchase reflects the fund's sustained interest in building a controlling minority position.

Portfolio skewed toward electrical equipment but diversified across sectors

Axiom Capital maintains 5%+ stakes in eight companies, with top holdings including Tokyo Cosmos Denki (6772, electrical equipment, 32.16%), Foster Electric (6794, electrical equipment, 22.66%), and Nippon Sangyo (9913, wholesale, 17%). The fund demonstrates marked concentration in electrical machinery but also holds positions across information and communications. Within this diversified portfolio, the 23.61% stake in Soken Chemical sits at a middling size, though it remains by far the fund's largest chemical sector holding.

Dominant position among disclosed Soken Chemical shareholders

Other large shareholders on record include Sumitomo Mitsui DS Asset Management (2.5%) and E Ink Holdings Inc. (1.01%). Axiom's 23.61% dwarfs these figures, establishing it as the company's principal institutional investor disclosed through large shareholding filings. The top two other investors combined hold only 3.51%, underscoring the scale of Axiom's commitment to Soken Chemical.

Valuation metrics and recent price momentum

At the time of filing, Soken Chemical traded at 23.6x earnings (PER) and 1.30x book value (PBR). A PER of 23.6x provides context only when compared to market benchmarks and sector peers; standing alone, it requires external reference points. The 1.30x PBR indicates equity trading at a 30% premium to accounting value, a moderate valuation. The stock's position at 64% within its 52-week range reflects a price closer to recent highs than lows, suggesting upward momentum in the months preceding the filing date.

*Speculation: By building ownership of roughly one quarter of this chemical manufacturer, Axiom Capital may be positioning itself to influence future strategic and capital allocation decisions at Soken Chemical.